Anthony Cheung
Oprichter bij ENGENE HOLDINGS INC.
Vermogen: 2 M $ op 30-04-2024
Profiel
Anthony T.
Cheung is the founder of enGene Holdings, Inc. (founded in 2023) and currently holds the title of Chief Technology Officer.
Dr. Cheung is also the founder of enGene,.
Inc...
Dr. Cheung's education history includes an undergraduate degree from the University of British Columbia and a doctorate degree from Tulane University School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ENGENE HOLDINGS INC.
0.23% | 18-03-2024 | 102 873 ( 0.23% ) | 2 M $ | 30-04-2024 |
Actieve functies van Anthony Cheung
Bedrijven | Functie | Begin |
---|---|---|
ENGENE HOLDINGS INC. | Oprichter | 24-04-2023 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Oprichter | - |
Opleiding van Anthony Cheung
University of British Columbia | Undergraduate Degree |
Tulane University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ENGENE HOLDINGS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |